Campanelle hopes to pick up Toast the City Best Restaurant win May 13, 2026 Campanelle is one of our favourite new Square Mile restaurants, a vast Italian dining room set inside the beautifully restored London Shipping Exchange on Billiter Street. Created by restaurateur Ninai Zarach, the all-day venue is an excellent showcase for grand City architecture. The menu takes inspiration from across Italy, catering for everything from breakfast meetings [...]
AI’s biggest problem is that it is trained to ‘please you’, warns tech chief May 13, 2026 The biggest risk facing AI may be that it becomes too good at telling users what they want to hear. Anthony Goonetilleke, chief tech officer at software firm Amdocs, told City AM businesses rushing to deploy AI are vastly underestimating a more subtle and potentially more dangerous problem emerging inside LLMs. “There’s another bucket I [...]
AI in banks? It’s all marketing and FOMO May 13, 2026 As banks are rush to beef up their AI capacity Samuel Norman recounts the sentiment shared across the industry at a conference in Copenhagen last week. Like all sectors, banks are chasing the promises of AI. The industry is shrugging off growing fears around job losses and rushing to beef up their AI credentials. Last [...]
Angelalign Technology Inc. (6699.HK) Applauds European Court Rejection of Patent Infringement Claim May 12, 2026 Angelalign Technology Inc. (6699.HK) (“Angel”) (http://www.angelaligner.com) today said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (ALGN) for Angel to cease and desist from using its A7 Premolar Extraction Solution. Angel denied that the A7 tooth movement protocol infringes any patents as [...]
Multi-Color Corporation Successfully Completes Comprehensive Financial Restructuring May 12, 2026 Company Emerges Stronger, Well-Positioned to Execute Long-Term Strategy With Significantly Deleveraged Balance Sheet
Elliptic Secures $120 Million Investment From Nasdaq Ventures, Deutsche Bank, One Peak and the British Business Bank May 12, 2026 The institutions building the future of finance are choosing Elliptic as the standard on-chain analytics for digital assets
Orbia Honored by Ragan for Storytelling Excellence as Chief People Officer Deb Butters is Recognized Among Top Women in HR May 12, 2026 Orbia has been recognized by Ragan with two major honors celebrating excellence in employee communications and leadership. The company has been named a winner in the Storytelling category of Ragan’s 2026 Employee Communications Awards for its global Generations of Impact campaign, while Orbia Executive Vice President and Chief People Officer Deb Butters was honored as [...]
Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference May 12, 2026 Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that Curtis Rambaran, MD, Chief Medical Officer of Silence Therapeutics, will participate in a fireside chat at the H.C. Wainwright BioConnect Investor Conference on Tuesday, May 19, 2026 at 2:00 p.m. ET. The live webcast can be [...]
GenNx360 Capital Partners Completes Sale of Precision Aviation Group to VSE Corporation for Approximately $2.025 Billion in Cash and Equity. May 12, 2026 GenNx360 Capital Partners (“GenNx360”), a New York-based private equity firm, has announced the sale of its portfolio company, Precision Aviation Group, Inc. (“PAG” or the “Company”), to VSE Corporation (“VSE”) for a total upfront consideration of approximately $2.025 billion in cash and equity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512000455/en/ Founded [...]
Alkermes Announces Positive Topline Results From REVITALYZ℠ Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia May 12, 2026 – LUMRYZ Met All Primary and Key Secondary Endpoints Demonstrating Statistically Significant and Clinically Meaningful Improvements Compared to Placebo in Excessive Daytime Sleepiness and Patient-Reported Disease Severity – – Safety Profile Consistent With Known Safety Profile of LUMRYZ –